Vinu José

1.6k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

Vinu José is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vinu José has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vinu José's work include HER2/EGFR in Cancer Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Molecular Biology Techniques and Applications (2 papers). Vinu José is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Molecular Biology Techniques and Applications (2 papers). Vinu José collaborates with scholars based in Belgium, Australia and France. Vinu José's co-authors include Sherene Loi, Mark J. Smyth, Christos Sotiriou, Heikki Joensuu, Christine Desmedt, Martine Piccart, Nicolas Sirtaine, Sibylle Loibl, Stefan Michiels and Vesa Kataja and has published in prestigious journals such as PLoS ONE, Cancer Research and Annals of Oncology.

In The Last Decade

Vinu José

8 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

2014 956 citations Sherene Loi, Stefan Michiels et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Vinu José

Since Specialization

Citations

This map shows the geographic impact of Vinu José's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinu José with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinu José more than expected).

Fields of papers citing papers by Vinu José

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinu José. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinu José. The network helps show where Vinu José may publish in the future.

Co-authorship network of co-authors of Vinu José

This figure shows the co-authorship network connecting the top 25 collaborators of Vinu José. A scholar is included among the top collaborators of Vinu José based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinu José. Vinu José is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer 2018 ·EBioMedicine ·Pushpamali De Silva, Soizic Garaud, Cinzia Solinas, Alexandre de Wind, Gert Van den Eyden, Vinu José, Chunyan Gu‐Trantien, Edoardo Migliori, Anaïs Boisson, Céline Naveaux, Hugues Duvillier, Ligia Craciun, Denis Larsimont, Martine Piccart, Karen Willard‐Gallo	34
2	Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays 2018 ·PLoS ONE ·Vinu José, Debora Fumagalli, Françoise Rothé, Samira Majjaj, Sherene Loi, Stefan Michiels, Christos Sotiriou	3
3	CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy 2017 ·Cancer Research ·Martin Turcotte, David Allard, Deepak Mittal, Yacine Barèche, Laurence Buisseret, Vinu José, Sandra Pommey, (unknown), Sherene Loi, Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Christos Sotiriou, Mark J. Smyth, John Stagg	94
4	Biology of breast cancer during pregnancy using genomic profiling 2014 ·Endocrine Related Cancer ·Hamdy A. Azim, (unknown), Fedro A. Peccatori, Christine Desmedt, Sherene Loi, Diether Lambrechts, Patrizia Dell’Orto, Samira Majjaj, Vinu José, Nicole Rotmensz, Michail Ignatiadis, Giancarlo Pruneri, M. Piccart, (unknown), (unknown)	47
5	Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial breakdown → 2014 ·Annals of Oncology ·Sherene Loi, Stefan Michiels, Roberto Salgado, Nicolas Sirtaine, Vinu José, Debora Fumagalli, Pirkko Kellokumpu‐Lehtinen, Petri Bono, Vesa Kataja, Christine Desmedt, Martine Piccart, Sibylle Loibl, Carsten Denkert, Mark J. Smyth, Heikki Joensuu, Christos Sotiriou	956
6	Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+ BC) 2013 ·Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·Sherene Loi, Stefan Michiels, Roberto Salgado, Nicolas Sirtaine, Vinu José, Debora Fumagalli, David N. Brown, Pirkko‐Liisa Kellokumpu‐Lehtinen, Petri Bono, Vesa Kataja, Christine Desmedt, Martine Piccart, Sibylle Loibl, Michael Untch, Carsten Denkert, Mark J. Smyth, Heikki Joensuu, Christos Sotiriou	29
7	Abstract S1-05: Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+ BC) 2013 ·Cancer Research ·Sherene Loi, Stefan Michiels, Roberto Salgado, Nicolas Sirtaine, Vinu José, Debora Fumagalli, (unknown), (unknown), Petri Bono, Vesa Kataja, Christine Desmedt, M. Piccart-Gebhart, Sibylle Loibl, Michael Untch, Carsten Denkert, Mark J. Smyth, Heikki Joensuu, Christos Sotiriou	26
8	Abstract P1-07-08: Effect of sample preservation method and transportation duration on tumor gene expression profiling in breast cancer. 2012 ·Cancer Research ·Debora Fumagalli, Vinu José, Roberto Salgado, Samira Majjaj, Sandeep K. Singhal, Delphine Vincent, Marion Maetens, Denis Larsimont, (unknown), Phuong Dinh, M. Piccart, Stefan Michiels, Christos Sotiriou, Sherene Loi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact